Recent research uncovers strong correlations between gut bacteria composition and physical function in seniors, suggesting microbiome-targeted interventions could combat frailty. Can the bacteria in y...
Life Biosciences launches a Phase I trial for cellular reprogramming to treat age-related macular degeneration, challenging aging norms with FDA’s Plausible Mechanism Pathway, amid rising invest...
Research reveals vitamin C’s role in inhibiting ACSL4, reducing iron-driven oxidative damage and senescence in cynomolgus monkeys, positioning it as a promising geroprotective target for human h...
A new multi-phase clinical trial on rapamycin aims to establish safe dosing for anti-aging, bridging the gap between off-label use and scientific validation in longevity medicine. Recent advancements ...
Senolytic and senomorphic therapies are advancing with compounds like RLS-1496 and α-ESA-me targeting senescent cells. Experts highlight challenges in biomarkers and safety, pushing for personalized ...
Aging research is pivoting from lifespan extension to enhancing healthspan, with innovations like senolytic drugs and digital health tools transforming clinical practices. Recent geroscience advances ...
Recent studies uncover autophagy’s dual role in aging, suggesting early enhancement through lifestyle may delay decline, while late-stage inhibition in senescent cells could reduce inflammation,...
Recent studies on hydra’s negligible senescence overturn traditional aging models, suggesting aging is adaptable and offering clues for anti-aging biotech interventions. New research reveals hyd...
Recent research indicates that nearly half of older adults can defy age-related decline through positive beliefs and structured interventions, enhancing cognitive and physical function. New studies re...
Golden spiny mice exhibit unique immune adaptations that slow aging and enhance regeneration, with recent studies offering hope for human healthspan therapies. Golden spiny mice demonstrate slowed agi...
